TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/21/22 16:06 | 3/18/22 | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Branning Todd P. | PA | O | CFO | P | 18 | 1.81 | 0 | 10 | 50 | 30 | D | ||||||||||||||
3/18/22 16:11 | 3/16/22 | NBSE | Neubase Therapeutics, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Branning Todd P. | PA | O | CFO | P.m | 34 | 1.68 | 0 | 20 | New | 20 | D | ||||||||||||||
1/23/20 17:42 | 1/22/20 | AMRX | Amneal Pharmaceuticals, Inc. | Health | Drug | Pharmaceutical Preparations | Branning Todd P. | NJ | O | SVP,CFO | M.d | 0 | 0.00 | 0 | 20 | 13 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |